Back
Bioxytran Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
50
BIXT
Bioxytran
Last Price:
0.1100
Seasonality Move:
2642.53%
Sell
42
NBY
NovaBay Pharmaceuticals
Last Price:
0.71
Seasonality Move:
-19.92%
Sell
50
Bioxytran (BIXT)
is a Sell
Is Bioxytran a Buy, Sell or Hold?
- The current Bioxytran [BIXT] share price is $0.1120. The Score for BIXT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BIXT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.71. The Score for NBY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIXT Stock Price Chart
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.71
The current trend is relatively stagnant and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
BIXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 59.63 | Buy |
| Chaikin Money Flow: | -16484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0844 - 0.1044) | Buy |
| Bollinger Bands (100): | (0.0849 - 0.1249) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 55.73 | Buy |
| Chaikin Money Flow: | -66635 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.46 - 0.7) | Buy |
| Bollinger Bands (100): | (0.33 - 3.11) | Sell |
BIXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.11 | Buy |
| 20-day SMA: | 0.1 | Buy |
| 50-day SMA: | 0.1 | Buy |
| 200-day SMA: | 0.11 | Sell |
| 8-day EMA: | 0.11 | Buy |
| 20-day EMA: | 0.1 | Buy |
| 50-day EMA: | 0.1 | Buy |
| 200-day EMA: | 0.12 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.71 | Buy |
| 20-day SMA: | 0.61 | Buy |
| 50-day SMA: | 0.55 | Buy |
| 200-day SMA: | 3.29 | Sell |
| 8-day EMA: | 0.7 | Buy |
| 20-day EMA: | 0.65 | Buy |
| 50-day EMA: | 0.87 | Sell |
| 200-day EMA: | 7.55 | Sell |
Bioxytran Earnings Growth & BIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Bioxytran Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||